CDISC Press Release-CDISC Announces New Additions to Board of Directors for 2013

Share Article

CDISC is pleased to announce that five highly qualified individuals will add invaluable expertise to the CDISC Board of Directors (BoD) for a three-year term beginning this month (2013—2016).

CDISC is pleased to announce that five highly qualified individuals will add invaluable expertise to the CDISC Board of Directors (BoD) for a three-year term beginning this month (2013—2016). Dr. Carolyn Compton, Michael Glickman, Dr. Douglas Peddicord, Stephen Pyke, and John Speakman each contribute unique skillsets to the BoD that will greatly assist CDISC as it moves forward with its Strategic Goals in 2013. Sincere appreciation goes to Dr. Steven Hirschfeld and Robert Goodwin, who completed their CDISC Board service in December 2012 and to Wayne Kubick who has become the Chief Technology Officer for CDISC.

Carolyn Compton, M.D. and Ph.D., is the current President and CEO of the Critical Path Institute (C-Path), which is partnered with CDISC through the Coalition For Accelerating Standards and Therapies (CFAST) and other initiatives such as the Coalition Against Major Diseases (CAMD) and the Critical Path to TB Drug Regimens (CPTR) through which the CDISC Alzheimer’s Disease and Tuberculosis standards were developed, respectively. Dr. Compton’s professional history is impressive, with 15 years spent as the Director of Gastrointestinal Pathology at the Massachusetts General Hospital, as a Professor of Pathology at Harvard Medical School and the Chair of Pathology and Pathologist-in-Chief at McGill University Health Center. Before taking on her current role at C-Path, Dr. Compton was Director of the Office of Biorepositories and Biospecimen Research and the Executive Director of the Cancer Human Biobank Project at the National Cancer Institute, where she was critical in implementing a number of key, groundbreaking research informatics solutions that were based on data standards.

Michael Glickman, MSE, is the founder and President of Computer Network Architects, Inc., through which he has worked with hundreds of healthcare organizations and has experience with every popular EHR system currently available. Mr. Glickman has over 45 years of experience in the computer industry, and during the last 35 years has specialized in the unique problems of systems integration in healthcare. His HIT expertise includes EHRs, Continuity of Care Record (CCR) integration, server consolidation, including “clinically reliable” business continuity/disaster recovery (BC/DR), enterprise PACS via enterprise SANs for all modalities, LAN/WAN/MAN technologies, voice convergence including unified communications (UC), patient care devices (PCD) and Health Information Exchange (HIE). Mr. Glickman was a founding member of the HL7 Working Group and currently serves as Chair of the U.S. Technical Advisory Group to ISO TC215 Health Informatics, in addition to many further prestigious activities.

Douglas Peddicord, Ph.D., serves as Executive Director of the Association of Clinical Research Organizations (ACRO), which has been a major supporter of CDISC and the move toward clinical data standards to improve the quality and efficiency of clinical trials. An early ACRO initiative involved the development of standardized case report forms (CRFs), a project that was eventually transitioned to CDASH. Dr. Peddicord is also President of Washington Health Strategies Group, LLC, which provides a full range of strategic consulting, government affairs and association management services to healthcare organizations. His particular areas of expertise include health information technology and medical privacy, clinical trials, medical informatics, and Medicare coverage and payment policy. He began his career on Capitol Hill in 1994 as an American Association for the Advancement of Science (AAAS) Fellow.

Stephen Pyke is Vice President of Quantitative Sciences at GlaxoSmithKline (GSK), with 17 years experience in the pharmaceutical industry. In his current role, Mr. Pyke leads a multidisciplinary group of 600 quantitative scientists spanning statistics and programming, clinical pharmacology modeling and simulation, epidemiology, genetics and computational biology. Mr. Pyke also has an accomplished history of involvement in various statistical societies, holding a number of honorary positions including Past-Chair and Board Member of Statisticians in the Pharmaceutical Industry (PSI), and is currently Vice President and Council member of the Royal Statistical Society.

John Speakman serves as Senior Director of Research Information Technology for the New York University (NYU) Langone Medical Center. He joined NYU in July 2012. He collaborates with the research community both at NYU and beyond with the goal of connecting people and technology to further the research mission of the Center in basic science, clinical trials, investigator-initiated and sponsored projects. Before July 2012, Mr. Speakman served at the National Cancer Institute (NCI) as Chief Program Officer for the Center for Biomedical Informatics and Information Technology, where he led NCI’s informatics programs, many of which involved partnering with CDISC in clinical research data standards. Mr. Speakman was re-elected to the CDISC Board this year after serving in 2012.

“We are privileged to have such a wealth of experience and expertise to augment our current CDISC Board of Directors in strategically advising CDISC Operations to ensure that we achieve the bold Strategic Goals we have set forth for the CDISC organization over the next three years,” said Paula Brown Stafford (Quintiles), current Chair of the CDISC Board. “I am pleased to welcome them all on behalf of CDISC, and am certain they will contribute significantly toward the CDISC vision of informing patient care and safety through higher quality medical research.”

CDISC is a 501(c)(3) global non-profit charitable organization, with nearly 300 supporting member organizations from across the clinical research and healthcare arenas. Through the efforts of volunteers around the globe, CDISC catalyzes productive collaboration to develop industry-wide data standards enabling the harmonization of clinical data and streamlining research processes from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data. The CDISC standards and innovations can decrease the time and cost of medical research and improve quality, thus contributing to the faster development of safer and more effective medical products and a learning healthcare system. The CDISC Vision is to inform patient care and safety through higher quality medical research.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Diana Harakeh
512 689 9646
Email >
Visit website